Illumina began taking orders for a new whole-genome expression product for rat that analyzes 12 samples in parallel on a single BeadChip. Content for the new RatRef-12 Expression BeadChip is derived ...
Illumina, Inc. (NASDAQ:ILMN) today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide ...
Illumina, Inc. has announced that it is collaborating with the Wellcome Trust Sanger Institute (WTSI) and the Wellcome Trust Case-Control Consortium (WT-CCC) on the design of a custom Sentrix® ...
Illumina, Inc. (NASDAQ:ILMN) today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS). Designed as ...
Microarray-based transcription profiling studies have provided important advances in our understanding of differential gene expression in heterogeneous cell populations—for example, in cancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results